Institutional investors purchased a net $668.8 thousand shares of ICLR during the quarter ended June 2017 and now own 98.40% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 636.0 Thousand shares of ICON PLC